• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人静脉血栓栓塞的危险因素:主登记研究结果

Risk factors for venous thromboembolism in the elderly: results of the master registry.

作者信息

Ageno Walter, Agnelli Giancarlo, Imberti Davide, Moia Marco, Palareti Gualtiero, Pistelli Riccardo, Rossi Romina, Verso Melina

机构信息

University of Insubria, Ospedale di Crcolo, Viale Borri 57, Varese, Italy.

出版信息

Blood Coagul Fibrinolysis. 2008 Oct;19(7):663-7. doi: 10.1097/MBC.0b013e3283079e58.

DOI:10.1097/MBC.0b013e3283079e58
PMID:18832907
Abstract

Approximately 50-75% of patients with venous thromboembolism have a readily identifiable risk factor, either transient or permanent, whereas the remaining episodes are classified as unprovoked. The incidence of first-time venous thromboembolism rises exponentially with age. Whether the prevalence and the relative weight of major risk factors differ between elderly and younger patients is unclear. We performed a multicenter, prospective, observational study on consecutive patients with objectively confirmed acute venous thromboembolism admitted to 25 Italian hospitals. Baseline characteristics and information on temporary and permanent risk factors at the time of the index event were secured by an electronic data network. We enrolled 2119 patients (49.8% men), of whom 440 (20%) were more than 75 years of age and 1679 (79.2%) 75 years of age or less. Elderly patients were more likely to have pulmonary embolism at presentation (33.6 and 25.6%, respectively, P < 0.001). After binary logistic regression analysis, we found that the risk of venous thromboembolism in the elderly, compared with the younger age group, was significantly associated with immobilization (odds ratio: 2.46, 95% confidence interval: 1.85-3.27) and with severe medical disorders (odds ratio: 1.99, 95% confidence interval: 1.41-2.80), whereas male sex (odds ratio: 0.53, 95% confidence interval: 0.42-0.66), surgery (odds ratio: 0.61, 95% confidence interval: 0.43-0.85), and trauma (odds ratio: 0.49, 95% confidence interval: 0.31-0.77) were less common risk factors in the elderly than in younger patients. Use of thromboprophylaxis prior to the index event was not different between the two age groups. Severe medical disorders and immobilization are strongly associated with the occurrence of venous thromboembolism in the elderly. Our findings stress the need for adequate thromboprophylaxis in this setting.

摘要

约50% - 75%的静脉血栓栓塞患者有一个易于识别的危险因素,该因素可以是短暂的或永久的,而其余发作被归类为特发性。首次静脉血栓栓塞的发病率随年龄呈指数上升。老年患者和年轻患者之间主要危险因素的患病率和相对权重是否不同尚不清楚。我们对意大利25家医院收治的经客观证实的急性静脉血栓栓塞连续患者进行了一项多中心、前瞻性观察研究。通过电子数据网络获取基线特征以及索引事件发生时临时和永久危险因素的信息。我们纳入了2119例患者(49.8%为男性),其中440例(20%)年龄超过75岁,1679例(79.2%)年龄在75岁及以下。老年患者就诊时更易发生肺栓塞(分别为33.6%和25.6%,P < 0.001)。经过二元逻辑回归分析,我们发现与年轻年龄组相比,老年患者发生静脉血栓栓塞的风险与制动(比值比:2.46,95%置信区间:1.85 - 3.27)和严重内科疾病(比值比:1.99,95%置信区间:1.41 - 2.80)显著相关,而男性(比值比:0.53,95%置信区间:0.42 - 0.66)、手术(比值比:0.61,95%置信区间:0.43 - 0.85)和创伤(比值比:0.49,95%置信区间:0.31 - 0.77)在老年患者中是比年轻患者更少见的危险因素。索引事件发生前预防性使用血栓药物在两个年龄组之间没有差异。严重内科疾病和制动与老年患者静脉血栓栓塞的发生密切相关。我们的研究结果强调了在这种情况下进行充分血栓预防的必要性。

相似文献

1
Risk factors for venous thromboembolism in the elderly: results of the master registry.老年人静脉血栓栓塞的危险因素:主登记研究结果
Blood Coagul Fibrinolysis. 2008 Oct;19(7):663-7. doi: 10.1097/MBC.0b013e3283079e58.
2
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry.与静脉血栓栓塞症诊断时机相关的因素:MASTER注册研究结果
Thromb Res. 2008;121(6):751-6. doi: 10.1016/j.thromres.2007.08.009. Epub 2007 Oct 24.
3
Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.孕期或产后静脉血栓栓塞:来自RIETE注册研究的结果
Thromb Haemost. 2007 Feb;97(2):186-90.
4
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.癌症相关急性静脉血栓栓塞的临床特征与管理:MASTER注册研究结果
Haematologica. 2008 Feb;93(2):273-8. doi: 10.3324/haematol.11458. Epub 2008 Jan 26.
5
Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study.长期制动是否为老年卧床患者发生症状性静脉血栓栓塞症的危险因素?一项历史性队列研究的结果
Thromb Haemost. 2004 Mar;91(3):538-43. doi: 10.1160/TH03-07-0481.
6
Racial and gender differences in the incidence of recurrent venous thromboembolism.复发性静脉血栓栓塞症发病率的种族和性别差异。
Thromb Haemost. 2006 Sep;96(3):267-73. doi: 10.1160/TH06-07-0365.
7
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.固定低剂量达肝素预防肥胖或老年住院患者静脉血栓栓塞的疗效和安全性:PREVENT试验的亚组分析
Arch Intern Med. 2005 Feb 14;165(3):341-5. doi: 10.1001/archinte.165.3.341.
8
The MASTER registry on venous thromboembolism: description of the study cohort.静脉血栓栓塞症的MASTER注册研究:研究队列描述
Thromb Res. 2008;121(5):605-10. doi: 10.1016/j.thromres.2007.06.009. Epub 2007 Aug 10.
9
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.海湾地区5个国家静脉血栓栓塞症患者的全球风险概况验证(GRIP VTE)
Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.
10
Statins decrease the occurrence of venous thromboembolism in patients with cancer.他汀类药物可降低癌症患者静脉血栓栓塞的发生。
Am J Med. 2010 Jan;123(1):60-5. doi: 10.1016/j.amjmed.2009.05.025.

引用本文的文献

1
Prediction model of deep vein thrombosis risk after lower extremity orthopedic surgery.下肢骨科手术后深静脉血栓形成风险的预测模型
Heliyon. 2024 Apr 16;10(9):e29517. doi: 10.1016/j.heliyon.2024.e29517. eCollection 2024 May 15.
2
Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.衰老在静脉血栓栓塞症中的病理生理学:更新。
Medicina (Kaunas). 2022 Aug 10;58(8):1078. doi: 10.3390/medicina58081078.
3
No apparent association between mRNA COVID-19 vaccination and venous thromboembolism.mRNA COVID-19 疫苗接种与静脉血栓栓塞之间无明显关联。
Blood Rev. 2022 Nov;56:100970. doi: 10.1016/j.blre.2022.100970. Epub 2022 May 11.
4
The Predictor Potential Role of the Glucose to Potassium Ratio in the Diagnostic Differentiation of Massive and Non-Massive Pulmonary Embolism.血糖钾比值在大面积与非大面积肺栓塞诊断鉴别中的预测作用。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221076146. doi: 10.1177/10760296221076146.
5
Rivaroxaban treatment for young patients with pulmonary embolism (Review).利伐沙班治疗年轻肺栓塞患者(综述)
Exp Ther Med. 2020 Aug;20(2):694-704. doi: 10.3892/etm.2020.8791. Epub 2020 May 25.
6
Current status of rivaroxaban in elderly patients with pulmonary embolism (Review).利伐沙班在老年肺栓塞患者中的现状(综述)
Exp Ther Med. 2020 Apr;19(4):2817-2825. doi: 10.3892/etm.2020.8559. Epub 2020 Feb 26.
7
Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report.低剂量利伐沙班治疗88岁女性肺栓塞的疗效:一例报告
Medicine (Baltimore). 2019 May;98(20):e15705. doi: 10.1097/MD.0000000000015705.
8
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.在患有静脉血栓栓塞症的老年患者中,多重用药与出血风险增加相关。
J Gen Intern Med. 2015 Jan;30(1):17-24. doi: 10.1007/s11606-014-2993-8. Epub 2014 Aug 21.
9
Hormonal contraception and thrombotic risk: a multidisciplinary approach.激素避孕与血栓风险:多学科方法。
Pediatrics. 2011 Feb;127(2):347-57. doi: 10.1542/peds.2010-2221. Epub 2011 Jan 3.